You are here

Home

CoPlex Therapeutics, LLC

Company Information
Address
A165 ASTeCC Bildg 145 Graham Ave.
Lexington, KY 40506-0286
United States
Information

UEI: JK7PN2MFXEU2

# of Employees: 2
Ownership Information

HUBZone Owned: Yes

Socially and Economically Disadvantaged: No

Woman Owned: No

Award Charts




Award Listing

  • Record 1 TO 3

  1. Commercialization of a Novel Therapeutic for Alzheimer's Disease

    Amount: $1,059,937.00

    ABSTRACT Traditional mon therapeutictarget driven approaches to drug development for Alzheimer s diseaseADare becoming increasingly expensive and in many cases disappointingly unsuccessfulBased on pre ...

    STTRPhase II2017Department of Health and Human Services National Institutes of Health

  2. Target Identification for Novel Small Molecule Therapeutic for Alzheimer's disease

    Amount: $106,301.00

    ABSTRACT Traditional approaches to drug development for Alzheimer s disease are becoming increasingly expensive and in many cases disappointingly unsuccessful Based on preliminary in vitro and in viv ...

    STTRPhase I2016Department of Health and Human Services National Institutes of Health

  3. Development of a Novel Therapeutic for Alzheimer' Disease

    Amount: $99,973.00

    DESCRIPTION (provided by applicant): Traditional approaches to drug development for Alzheimer's disease are becoming increasingly expensive and in many cases disappointingly unsuccessful. Based o ...

    STTRPhase I2012Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government